Conversion surgery for microsatellite instability-high gastric cancer with a complete pathological response to pembrolizumab: a case report

BACKGROUND: Immune checkpoint inhibitors are reportedly effective in treating microsatellite instability (MSI)-high gastric cancer. There are a few case reports of conversion surgery (CS) with nivolumab but none with pembrolizumab. Herein, we describe a patient with MSI-high gastric cancer who was s...

Descripción completa

Detalles Bibliográficos
Autores principales: Hidaka, Yoshifumi, Arigami, Takaaki, Osako, Yusaku, Desaki, Ryosuke, Hamanoue, Masahiro, Takao, Sonshin, Kirishima, Mari, Ohtsuka, Takao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9185925/
https://www.ncbi.nlm.nih.gov/pubmed/35689267
http://dx.doi.org/10.1186/s12957-022-02661-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9185925/
https://www.ncbi.nlm.nih.gov/pubmed/35689267
http://dx.doi.org/10.1186/s12957-022-02661-8

Ejemplares similares